BCRX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BioCryst Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 9.035 USD -2.22% Market Closed

Market Cap: $2.3B

	BioCryst Pharmaceuticals Inc NASDAQ:BCRX	US
	Miller Industries Inc NYSE:MLR	US
	Stewart Information Services Corp NYSE:STC	US
P	Petroleo Brasileiro SA Petrobras XMUN:PJXA	BR
	Japan Steel Works Ltd TSE:5631	JP
	Wix.Com Ltd NASDAQ:WIX	IL
U	United Labels AG XMUN:ULC	DE
C	Credit Saison Co Ltd XMUN:QC9	JP

Profitability Summary

BioCryst Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

97% > 98%

Exceptional Operating Margin

36%

Negative 3Y Average Operating Margin

-2%

Operating Margin is Increasing

-37% > 36%

Negative Net Margin

-52%

Negative 3Y Average Net Margin

-30%

Net Margin is Increasing

-79% > -52%

Exceptional Free Cash Flow Margin

35%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

-40% > 35%

Exceptional ROE

91%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.